News
22m
InvestorsHub on MSNGSK shares rise after FDA grants priority review for oral gonorrhea antibioticGSK (NYSE:GSK) announced Monday that the U.S. Food and Drug Administration has accepted its priority review application for ...
GSK (NYSE:GSK) (LON:GSK) said on Monday that the U.S. Food and Drug Administration has accepted its priority review ...
Adams, who served as surgeon general during the first Trump administration, said Kennedy's assertions about the efficacy of ...
CureVac ( (CVAC)) has provided an announcement. On August 7, 2025, CureVac announced the resolution of U.S. patent litigation with Pfizer/BioNTech concerning mRNA-based COVID-19 vaccines. As part of ...
The U.S. Department of Health and Human Services (HHS) has announced a sweeping plan to wind down its mRNA vaccine ...
A top official at the Department of Health and Human Services (HHS) has been fired, igniting a firestorm of controversy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results